MA-OLYMPUS
Olympus’ new Vanta ™ handheld XRF analyzer is designed for durability in harsh industrial environments, providing maximum uptime and a low cost of ownership. The instruments in the Vanta family provide fast and accurate elemental analysis and quantification for a wide variety of materials in as little as 1–2 seconds. Combined with revolutionary new Axon™ technology, results are faster, more accurate and more reliable than ever.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160906005174/en/
Vanta analyzers are the only handheld XRF devices that are IP65 rated for protection against dust and water and drop tested to military standards. Their rugged design enables the analyzers to work in harsh environments for applications such as positive material identification (PMI), scrap recycling, and mining with fewer repairs. With Vanta analyzers, users obtain lab-quality results no matter the setting. Rugged features include:
- IP65* rated for protection against dust and water
- 4-foot drop tested (MIL-STD 810G)
- Built to withstand a temperature range of -10 °C to 50 °C (14 °F to 122 °F)1
- Protective detector shutter on silicon drift detector models
Every Vanta handheld XRF analyzer incorporates Olympus’ revolutionary new Axon technology, a breakthrough in XRF signal processing that utilizes ultra-low-noise electronics to deliver higher X-ray count rates per second and fast results. The hardware and user interface are designed to be easy to use so new operators can begin using the device with minimal training. A range of application-specific software features improve user productivity for a fast return on investment. Vanta analyzers feature:
- Quad-core processor and Axon technology
- Intuitive UI with customizable home screen
- Vivid touch screen readable in any light
- Optional Wi-Fi and Bluetooth® functionality for seamless data transfer
- Embedded GPS for XRF data spatial tracking
- Library of over 700 alloys for metals analysis
Vanta analyzers combine durability, power, and ease of use for excellence in applications including scrap recycling, mining, fabrication QA/QC, positive material identification (PMI), environmental assessment, RoHS compliance, consumer product safety, scientific research and education.
About Olympus
Olympus Corporation operates in industrial, medical, and consumer markets, specializing in optics, electronics, and precision engineering. Olympus is a world-leading manufacturer of innovative test and measurement solutions that are used in industrial and research applications ranging from aerospace, power generation, petrochemical, civil infrastructure, and automotive to consumer products.
For more information about Vanta handheld XRF analyzers and Olympus’ line of nondestructive testing products contact a sales representative or visit www.olympus-ims.com .
1 With optional fan. The fan assembly is IP56 rated. Operates continuously at 33 °C without the fan.
*M series analyzers are IP64 rated.
Bluetooth word mark and logos
are registered trademarks owned by Bluetooth SIG, Inc. and any use of
such marks by Olympus Corporation is under license.
Vanta and Axon
are trademarks of Olympus Corporation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160906005174/en/
Contact:
Media Contact
:
Olympus Corporation
Hilary Banda,
781-419-3624
hilary.banda@olympus-ossa.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom